New Cousteau-Linked...
Allied Healthcare Products (AHPI: NASDAQ)
$3.15 0.05 | 1.61%
06/01/12 - 03:49 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.15 |
| 52 Week High | 4.69 |
| 52 Week Low | 3.07 |
| Avg. Daily Vol. (Mil) | 0.00 |
| Beta (3 year) | -0.07 |
| Share Related Items | |
| Mkt Cap (Mil) | 25.59 |
| Shares Out (Mil) | 8.12 |
| Float (Mil) | 2.96 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.40 |
| Current Ratio | 4.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.57 |
| Price/Book | 0.95 |
| Price/Cash Flow | 23.60 |
| Per Share Data | |
| Earnings | -0.02 |
| Sales | 5.52 |
| Book Value | 3.31 |
| Cash Flow | 0.13 |
| Business Summary | |
|---|---|
| Allied Healthcare Products manufactures and markets respiratory products, including respiratory care products, medical gas equipment and emergency medical products. | |
| General Information | |
| 1720 Sublette Avenue
St. Louis, MO 63110 |
|
| www.alliedhpi.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 313 | |
| CEO: Mr. Earl R. Refsland | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 1.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -0.50 |
| Return on Investments | -0.60 |
| Profitability | |
| Gross Margin | 26.20 |
| EBIT Margin | -0.50 |
| Profit Margin | -0.30 |
Portfolios with AHPI
- Portfolio NameUser Type
- Usermbennyc100 Portfolio 1
Latest AHPI Headlines from TheStreet
- Allied Healthcare Products Stock Upgraded By TheStreet Ratings (AHPI) 02.16.11 | 05:02 pm
Press Releases for AHPI
- Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used In Anesthesia - PR Newswire 06.17.10 | 07:06 pm
- Allied Healthcare Products Returns To Profitability By Offsetting Depressed Sales With Cost Reductions - PR Newswire 02.08.10 | 08:02 pm





